At PGXIS, we use our expertise to:
- Enhance the efficiency of drug discovery & development, making more medicines available to meet the needs of patients
- Increase the clinical effectiveness of medicines so that patients taking the medicines receive maximum benefit
|
To do this, we have four parts to our business:
1) Building a pipeline of candidate drug assets
2) Pharmacogenetics consultancy services
3) Cutting edge cell transfection and siRNA technology
4) A novel statistical approach (Tax3) to complex datasets
|
|
